Buys | $445,572 | 1 | 8 |
Sells | $968,443 | 11 | 92 |
MATEO ALAN | director | 1 | $445,572 | 0 | $0 | $445,572 |
McAnear Justin J. | Chief Financial Officer | 0 | $0 | 2 | $138,066 | $-138,066 |
Hindson Benjamin J. | See Remarks | 0 | $0 | 4 | $327,444 | $-327,444 |
Saxonov Serge | Chief Executive Officer | 0 | $0 | 5 | $502,933 | $-502,933 |
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for …
Over the last 12 months, insiders at 10x Genomics, Inc. have bought $445,572 and sold $968,443 worth of 10x Genomics, Inc. stock.
On average, over the past 5 years, insiders at 10x Genomics, Inc. have bought $229,183 and sold $281.78M worth of stock each year.
Highest buying activity among insiders over the last 12 months: MATEO ALAN (director) — $445,572.
The last purchase of 40,000 shares for transaction amount of $445,572 was made by MATEO ALAN (director) on 2025‑02‑21.
2025-02-28 | Sale | Saxonov Serge | Chief Executive Officer | 7,942 0.0065% | $10.63 | $84,393 | +0.09% | |
2025-02-24 | Sale | Saxonov Serge | Chief Executive Officer | 5,092 0.0042% | $11.07 | $56,346 | -4.38% | |
2025-02-24 | Sale | Hindson Benjamin J. | See Remarks | 4,573 0.0038% | $11.07 | $50,603 | -4.38% | |
2025-02-21 | MATEO ALAN | director | 40,000 0.0315% | $11.14 | $445,572 | -5.88% | ||
2024-11-22 | Sale | Saxonov Serge | Chief Executive Officer | 6,693 0.0052% | $13.69 | $91,612 | +2.52% | |
2024-11-22 | Sale | Hindson Benjamin J. | See Remarks | 5,807 0.0045% | $13.69 | $79,485 | +2.52% | |
2024-08-22 | Sale | Saxonov Serge | Chief Executive Officer | 6,749 0.0057% | $22.53 | $152,053 | -30.61% | |
2024-08-22 | Sale | Hindson Benjamin J. | See Remarks | 4,351 0.0037% | $22.53 | $98,027 | -30.61% | |
2024-08-22 | Sale | McAnear Justin J. | Former Chief Financial Officer | 2,961 0.0025% | $22.53 | $66,710 | -30.61% | |
2024-05-22 | Sale | Saxonov Serge | Chief Executive Officer | 4,877 0.0041% | $24.30 | $118,529 | -32.20% | |
2024-05-22 | Sale | Hindson Benjamin J. | See Remarks | 4,087 0.0034% | $24.30 | $99,329 | -32.20% | |
2024-05-22 | Sale | McAnear Justin J. | Chief Financial Officer | 2,936 0.0025% | $24.30 | $71,355 | -32.20% | |
2024-03-04 | Sale | Saxonov Serge | Chief Executive Officer | 4,660 0.0038% | $44.00 | $205,021 | -56.02% | |
2024-02-22 | Sale | Saxonov Serge | Chief Executive Officer | 2,821 0.0028% | $46.34 | $130,737 | -56.32% | |
2024-02-22 | Sale | Hindson Benjamin J. | See Remarks | 2,613 0.0026% | $46.34 | $121,098 | -56.32% | |
2024-02-22 | Sale | McAnear Justin J. | Chief Financial Officer | 1,865 0.0018% | $46.34 | $86,432 | -56.32% | |
2024-02-15 | Sale | Saxonov Serge | Chief Executive Officer | 5,000 0.0043% | $48.87 | $244,332 | -58.37% | |
2024-02-09 | Sale | Saxonov Serge | Chief Executive Officer | 1,000 0.001% | $49.53 | $49,530 | -59.12% | |
2024-01-16 | Sale | Saxonov Serge | Chief Executive Officer | 4,000 0.0034% | $45.24 | $180,956 | -51.06% | |
2023-12-14 | Sale | Saxonov Serge | Chief Executive Officer | 2,000 0.0017% | $55.03 | $110,065 | -59.07% |
McAnear Justin J. | Former Chief Financial Officer | 143242 0.1171% | $1.48M | 1 | 38 | <0.0001% |
MATEO ALAN | director | 61691 0.0504% | $637,884.94 | 1 | 0 | |
Foresite Capital Management I, LLC | 10 percent owner | 2350000 1.9215% | $24.3M | 1 | 2 | +46.56% |
ROBERTS BRYAN E | director | 1287825 1.053% | $13.32M | 1 | 1 | +41.14% |
CRUTCHFIELD BRADFORD | Chief Commercial Officer | 97237 0.0795% | $1.01M | 1 | 31 | <0.0001% |
Increased Positions | 153 | +47.66% | 19M | +17.34% |
Decreased Positions | 144 | -44.86% | 17M | -15.71% |
New Positions | 63 | New | 12M | New |
Sold Out Positions | 52 | Sold Out | 7M | Sold Out |
Total Postitions | 330 | +2.8% | 109M | +1.63% |
Fmr Llc | $139,119.00 | 12.46% | 13.45M | +86,455 | +0.65% | 2024-12-31 |
Ark Investment Management Llc | $123,502.00 | 11.06% | 11.94M | +1M | +11.1% | 2024-12-31 |
Vanguard Group Inc | $113,053.00 | 10.12% | 10.93M | -39,381 | -0.36% | 2024-12-31 |
Blackrock, Inc. | $70,004.00 | 6.27% | 6.77M | -45,119 | -0.66% | 2024-12-31 |
Sumitomo Mitsui Trust Group, Inc. | $59,077.00 | 5.29% | 5.71M | -659,728 | -10.35% | 2024-12-31 |
Nikko Asset Management Americas, Inc. | $59,077.00 | 5.29% | 5.71M | -659,728 | -10.35% | 2024-12-31 |
Morgan Stanley | $40,587.00 | 3.64% | 3.93M | -3M | -39.39% | 2024-12-31 |
Ra Capital Management, L.P. | $33,909.00 | 3.04% | 3.28M | +3M | New | 2024-12-31 |
Ubs Am, A Distinct Business Unit Of Ubs Asset Management Ame | $21,885.00 | 1.96% | 2.12M | +193,588 | +10.07% | 2024-12-31 |
Venrock Management Vi, Llc | $21,784.00 | 1.95% | 2.11M | 0 | 0% | 2024-09-30 |